Aetna supports landmark study on BRCA testing Testing is available to help identify in the event that a woman will probably face among her gender’s worst fears: inherited breast and ovarian malignancy read . But significant queries have been raised among doctors and public health organizations about whether these exams are on offer to the women who can most advantage – in keeping with the evidence-based suggestions for this testing – and whether the info learned from testing has been put to best use.
The brand new Axiom 384HT format addresses a current market need by providing scientists with an extremely economical method of quickly genotyping samples across up to 50,000 markers. Researchers can transfer articles from Axiom 96-layout arrays used in sequencing validation and GWAS studies to Axiom 384-layout arrays with 100 percent fidelity and features. The high-throughput assay combined with Axiom software program for automated genotype phoning in diploid and complicated polyploid species provides an elegant and superior system for routine genotyping applications.